PATRICIA ARES-ROMERO: Open Payments
NPI 1902823719 · HANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176,557 in 202 payments from 8 companies in 2025. Trend: 2023 $46,409 · 2024 $76,525 · 2025 $176,557
Speaker / faculty: $112,276Consulting: $35,202Travel & lodging: $23,439Food & beverage: $5,640
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 119 | $114,931 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 42 | $37,086 |
| Neurocrine BioSciences, Inc. | 32 | $24,107 |
| Alkermes, Inc. | 5 | $156 |
| Boston Scientific Corporation | 1 | $156 |
| Biogen, Inc. | 1 | $71 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
Products named: COBENFY, CAPLYTA, INGREZZA, WATCHMAN FLX, LYBALVI, ZURZUVAE, ARISTADA, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
